Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada

    Feb 22, 2024, 08:23 AM by
    TriLink’s CleanCap® Capping Technology is Patented Globally & TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs
    Full story
  • Healthcare 2.0: How Precision Medicine Sector is Reshaping the Future

    Feb 22, 2024, 08:23 AM by
    Full story
  • Biotium Expands Selection of Novel Nuclear Stains for Enhanced Multiplexing Flexibility for Microscopy and Flow Cytometry Applications

    Feb 22, 2024, 08:23 AM by
    Biotium has announced the expansion of its NucSpot® Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining.
    Full story
  • AES Clean Technology appoints new Vice President of Engineering

    Feb 22, 2024, 08:23 AM by
    AES Clean Technology appoints new Vice President of Engineering  Montgomeryville, Pennsylvania, February 20th, 2024: AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering. With over 20 years of experience in the life science industry and deep expertise in engineering and project delivery, Chris will oversee all aspects of engineering operations, including product development, innovation, and technological advancement initiatives that are aligned with AES’ strategic vision. In addition, he will focus on streamlining the team’s processes, driving consistency, and fostering a culture of technical excellence and innovation.
    Full story
  • Proteomics Approach Working Its Way To The Clinic For Stubborn Cancers

    Feb 22, 2024, 01:00 AM by User Not Found
    Bio-IT World | For roughly half of patients with recurrence of often-deadly glioblastoma multiforme (GBM), their tumors are characterized by cells that look a lot like healthy neurons. The mimicry trick was discovered by proteomics, which has opened a view to tumor alterations unavailable through genetics alone.
    Full story
  • Horizon CME Announces First Annual Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)

    Feb 21, 2024, 06:14 AM by
    Horizon CME has announced its sponsorship of the first annual summit for the multidisciplinary conference, Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer).
    Full story
  • ENPICOM partners with Erasmus University Medical Center in groundbreaking effort to discover nanobodies against cancer

    Feb 21, 2024, 06:14 AM by
    ENPICOM has announced a collaboration with Erasmus Medical Center. This partnership aims to identify and develop nanobodies against cancer by utilizing ENPICOM’s immune repertoire data analysis services and software solutions.
    Full story
  • Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology

    Feb 20, 2024, 08:41 AM by
    Full story
  • The Rise of Digital Biomarkers: Revolutionizing Healthcare Monitoring

    Feb 20, 2024, 08:41 AM by
    The global digital biomarkers market showcased remarkable growth, reaching a valuation of USD 3.55 billion in 2023. Projections indicate an exponential trajectory, with expectations to soar to approximately USD 26.79 billion by 2033. This impressive growth is anticipated to occur at a robust compound annual growth rate (CAGR) of 22.4% during the forecast period spanning from 2024 to 2033.
    Full story
  • Latest Oral Insulin Drug Making Its Way To Clinical Trials

    Feb 20, 2024, 01:00 AM by User Not Found
    Bio-IT World | More than a century has passed since the discovery of insulin, the world's first life-saving treatment for diabetes, and it is still being delivered via injection despite several brushes with success in developing an oral version of the drug. Hope is again on the horizon with the emergence of an oral nanotherapeutic formulation of insulin that comes with the possibility of reducing if not eliminating hypoglycemic events.
    Full story
  • Alfa Chemistry Unveils Expanded Assortment of Derivatization Reagents for Use in Gas Chromatography (GC)

    Feb 19, 2024, 08:39 AM by
    Full story
  • Biomaterials, Another Key Player in Advanced Drug Delivery Systems, Interact Seamlessly with Biological Systems, Facilitating the Controlled Release of Medications

    Feb 19, 2024, 08:39 AM by
    In the fight against infectious diseases like HIV/AIDS, tuberculosis, and viral hepatitis, scientists are turning to advanced drug delivery for more effective treatments. These systems use tiny particles called nanoparticles to carry antiviral and antimicrobial drugs directly to the infected tissues in the body. By doing this, they can target the specific areas where the viruses or bacteria are causing harm while reducing the risk of side effects in other body parts.
    Full story
  • Amerigo Scientific Launches DOPC Nanodiscs as An Invaluable Tool for Handling Membrane Proteins

    Feb 19, 2024, 08:39 AM by
    Full story
  • CD BioSciences Announces Its Self-Developed Alginate Products, Looking to Fulfill Research Needs

    Feb 19, 2024, 08:39 AM by
    CD BioSciences is pleased to announce the launch of their latest self-developed alginate products, looking to fulfill scientific research demands.
    Full story
  • New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients

    Feb 16, 2024, 09:06 AM by
    New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients
    Full story
  • SinguLab® Announces Integration with PointClickCare

    Feb 15, 2024, 10:39 AM by
    Precision medicine and diagnostics solutions company SinguLab has partnered with PointClickCare Technologies Inc., provider of a cloud-based software platform for the senior care continuum, to improve precision care capabilities and access in the long-term and post-acute care (LTPAC) space.
    Full story
  • Eagle Product Inspection Highlights the Pack 320 PRO X-ray Machine

    Feb 15, 2024, 10:39 AM by
    Superior x-ray inspection of high-speed flow-wrap lines
    Full story
  • Optibrium enables collaborative design in its StarDrop platform

    Feb 15, 2024, 08:45 AM by
    Optibrium today announced the release of StarDrop 7.6, the latest version of its platform for small molecule design, optimisation and analysis. As part of the release, Optibrium introduces a new extension, Idea Tracker, with which medicinal chemists can now easily trace molecular design and optimisation decisions through every step of the complex discovery process, from idea conception to selecting candidates for synthesis.
    Full story
  • REMEDI8 Highlights Mobile Containment Unit for Infection Control in the Healthcare Industry

    Feb 15, 2024, 08:45 AM by
    HEPA-10X mitigates the spread of infection in high-risk healthcare environments
    Full story
  • Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs

    Feb 15, 2024, 08:45 AM by
    New Thermo Scientific Dionex Inuvion Ion Chromatography System streamlines ion analysis and expands analytical testing capabilities for ionic and small polar compounds
    Full story
  • «
  • 41
  • 42
  • 43
  • 44
  • 45 (current)
  • 46
  • 47
  • 48
  • 49
  • 50
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy